dexmedetomidine has been researched along with Acute Disease in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, J; Lan, J; Peng, W; Zheng, J | 1 |
| Hou, CQ; Huang, DY; Li, Q; Miao, Y; Shen, HB; Shi, CY | 1 |
| Bell, CM; Parli, SE; Procter, LD | 1 |
| Amigoni, A; Blangetti, I; Casella, G; Chelazzi, C; Conti, G; Forfori, F; Garisto, C; Moltrasio, M; Mondardini, MC; Pasero, D; Principi, T; Ricci, Z; Romagnoli, S; Tarantino, F | 1 |
| Díaz-Fuentes, G; Hernández-Torres, J; Pérez-Lara, JL; Santana, Y | 1 |
| Al-Qadheeb, NS; Chi, A; Devlin, JW; Garpestad, E; Hill, NS; Qawi, I; Roberts, RJ | 1 |
| Chen, H; Liu, L; Liu, X; Wang, H; Wang, L; Wang, M | 1 |
| Dodds, MM; Frazer, CD; Lipman, J; Reade, M | 1 |
| Brederlau, J; Gerresheim, G; Schwemmer, U | 1 |
| Asaro, LA; Cowl, AS; Curley, MA; Dodson, BL; Grant, MJ; Hall, BA; Munkwitz, MM; Schneider, JB; Simone, SL; Wypij, D | 1 |
| Barbi, E; Cozzi, G; Giorgi, R; Lega, S | 1 |
| Kido, T; Semba, K; Takasaki, Y | 1 |
| Calver, L; Isbister, GK | 1 |
| Citil, M; Hanci, V; Kiliç, K; Kiliç, N; Selek, S; Sözmen, M; Yurtlu, BS; Yurtlu, DA | 1 |
| Angus, JA; Tham, SM; Tudor, EM; Wright, CE | 1 |
| Blake, DW; Ludbrook, J; Van Leeuwen, AF | 1 |
2 review(s) available for dexmedetomidine and Acute Disease
| Article | Year |
|---|---|
Light sedation with dexmedetomidine: a practical approach for the intensivist in different ICU patients.
Topics: Acute Disease; Adult; Cardiac Surgical Procedures; Cerebrovascular Disorders; Child; Conscious Sedation; Critical Care; Critical Illness; Deep Sedation; Delirium; Dexmedetomidine; Humans; Hypnotics and Sedatives; Intensive Care Units; Sepsis | 2018 |
Acute Colonic Pseudo-Obstruction Caused by Dexmedetomidine: A Case Report and Literature Review.
Topics: Acute Disease; Colonic Pseudo-Obstruction; Dexmedetomidine; Humans; Hypnotics and Sedatives; Male; Middle Aged | 2019 |
2 trial(s) available for dexmedetomidine and Acute Disease
| Article | Year |
|---|---|
Efficacy and safety of early dexmedetomidine during noninvasive ventilation for patients with acute respiratory failure: a randomized, double-blind, placebo-controlled pilot study.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Dexmedetomidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fentanyl; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Pilot Projects; Respiration, Artificial; Respiratory Insufficiency; Treatment Outcome | 2014 |
Dexmedetomidine Use in Critically Ill Children With Acute Respiratory Failure.
Topics: Acute Disease; Adolescent; Airway Extubation; Child; Child, Preschool; Critical Care; Critical Illness; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Intubation, Intratracheal; Male; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Treatment Outcome | 2016 |
12 other study(ies) available for dexmedetomidine and Acute Disease
| Article | Year |
|---|---|
Nrf2 mediates the antinociceptive activity of dexmedetomidine in an acute inflammatory visceral pain rat model by activating the NF-κB sensor.
Topics: Acute Disease; Analgesics; Animals; Dexmedetomidine; Disease Models, Animal; Inflammation; Male; NF-E2-Related Factor 2; NF-kappa B; Nociception; Rats; Rats, Sprague-Dawley; Visceral Pain | 2020 |
Dexmedetomidine attenuates inflammation and pancreatic injury in a rat model of experimental severe acute pancreatitis via cholinergic anti-inflammatory pathway.
Topics: Acute Disease; Animals; Dexmedetomidine; Inflammation; Neuroimmunomodulation; Pancreatitis; Rats; Tumor Necrosis Factor-alpha | 2020 |
Asystole Following Concomitant Intravenous Administration of Neostigmine and Dexmedetomidine in a Patient With Acute Colonic Pseudo-Obstruction.
Topics: Acute Disease; Bradycardia; Colonic Pseudo-Obstruction; Dexmedetomidine; Heart Arrest; Humans; Infusions, Intravenous; Neostigmine | 2022 |
Acute hyperglycemia prevents dexmedetomidine-induced preconditioning against renal ischemia-reperfusion injury.
Topics: Acute Disease; Animals; Apoptosis; Blood Glucose; Creatinine; Dexmedetomidine; Hyperglycemia; Ischemia; Ischemic Preconditioning; Kidney; Kidney Tubules; Male; Models, Animal; Nephrectomy; Proto-Oncogene Proteins c-akt; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury; Urea | 2014 |
Use of neostigmine for acute colonic pseudo-obstruction in a patient receiving dexmedetomidine.
Topics: Acute Disease; Analgesics, Non-Narcotic; Bradycardia; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Dexmedetomidine; Humans; Male; Middle Aged; Neostigmine | 2016 |
[Dexmedetomidine in the treatment of acute alcohol withdrawal delirium].
Topics: Acute Disease; Adult; Alcohol Withdrawal Delirium; Anticonvulsants; Critical Care; Dexmedetomidine; Guidelines as Topic; Humans; Hypnotics and Sedatives; Male | 2016 |
Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation.
Topics: Acute Disease; Administration, Intranasal; Anxiety; Asthma; Child, Preschool; Dexmedetomidine; Emergency Service, Hospital; Female; Humans; Hypnotics and Sedatives; Infant; Psychomotor Agitation | 2017 |
Dexmedetomidine facilitates induction of noninvasive positive pressure ventilation for acute respiratory failure in patients with severe asthma.
Topics: Acute Disease; Adult; Aged; Asthma; Critical Care; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Male; Positive-Pressure Respiration; Respiratory Insufficiency; Respiratory Mechanics | 2009 |
Dexmedetomidine in the emergency department: assessing safety and effectiveness in difficult-to-sedate acute behavioural disturbance.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Attention Deficit and Disruptive Behavior Disorders; Dexmedetomidine; Emergency Medicine; Emergency Service, Hospital; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Young Adult | 2012 |
The effects of dexmedetomidine on mesenteric arterial occlusion-associated gut ischemia and reperfusion-induced gut and kidney injury in rabbits.
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Animals; Antioxidants; Arterial Occlusive Diseases; Dexmedetomidine; Disease Models, Animal; Intestinal Mucosa; Intestines; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Mesenteric Arteries; Oxidants; Peroxidase; Rabbits; Reperfusion Injury; Treatment Outcome | 2012 |
Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Topics: Acute Disease; Adrenergic alpha-Agonists; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cannabinoids; Cyclohexanols; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Synergism; Injections, Spinal; Male; Mice; Morphine; Pain; Pain Measurement; Receptors, Opioid, mu | 2005 |
Dexmedetomidine and haemodynamic responses to acute central hypovolaemia in conscious rabbits.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alfentanil; Animals; Blood Flow Velocity; Dexmedetomidine; Drug Therapy, Combination; Female; Hemodynamics; Hemorrhage; Idazoxan; Infusions, Intravenous; Injections, Intraventricular; Pressoreceptors; Rabbits; Shock; Vasoconstriction; Vena Cava, Inferior | 2000 |